Is bone scanning of value in patients with breast cancer?
Spencer, G.R.; Khan, M.; Bird, C.; Seymour, R.; Brown, T.R.; Collins, C.D.
Acta Chirurgica Scandinavica 147(4): 247-248
1981
ISSN/ISBN: 0001-5482 PMID: 6459704 Document Number: 175994
Over the last decade, bone scans have played an increasingly important role in the management of patients with breast carcinoma; by detecting both occult and symptomatic bony metastases. 234 bone scans carried out in this hospital in 1978/79 on patients with breast cancer, at considerable cost to the NHS, are reviewed.
Document emailed within 1 workday
Related Documents
Dibekoglu, C.; Turanli, S.; Karaman, N.; Ozcelik, K.C.; Erdogan, O. 2015: Bone fracture in breast cancer patients with isolated bone metastasis Chirurgia 110(1): 43-48Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Zissimopoulos, A.; Matthaios, D.; Matthaiou, E.; Mantadakis, E.; Karaitianos, I. 2007: Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(4): 505-511
Bok, B.; Rondier, J.; M'Timet, S.; Brossel, R.; Cayla, J. 1974: Current role of strontium 87m bone scanning for the detection of secondary bone cancer Pathologie-Biologie 22(3): 231-240
Incorvaia, L.; Badalamenti, G.; Rini, G.; Arcara, C.; Fricano, S.; Sferrazza, C.; Di Trapani, D.; Gebbia, N.; Leto, G. 2007: MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Research 27(3b): 1519-1525
Hortobagyi, G.N. 1991: Bone metastases in breast cancer patients Seminars in Oncology 18(4 Suppl 5: 11-15
Korman, D.B.; Borisov, A.I.; Maslova, I.A.; Dobroskok, L.B. 1980: Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases Voprosy Onkologii 26(8): 20-24
Theriault, R. 1996: Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients British Journal of Clinical Practice. Suppl 87: 8
Udani, S.K.; Qureshi, S.A.; Lateef, T.; Jafri, L.; Effendi, M.U.N.; Raheem, A.; Azmi, M.B.; Rais, S.; Jahan, M.; Mudassir, H.A.; Akram, B.; Alvi, M.; Khan, S.; Ghani, F. 2019: Vitamin D and bone metabolism in breast cancer patients in Karachi, Pakistan Pakistan Journal of Pharmaceutical Sciences 32(2): 875-880
Taguchi, T. 2011: Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer Clinical Calcium 21(3): 429-438
Schwarz, I.; Eichfeld, U.; Gläser, A. 1992: Immunocytologic tumor cell detection in bone marrow of breast cancer patients Zeitschrift für Arztliche Fortbildung 86(19): 977-980
Lagrange, J.L.; Frenay, M.; Darcourt, J.; François, E.; Héry, M.; Namer, M.; Lapalus, F. 1990: Should systematic bone scintigraphy be carried out on breast cancer patients with small tumors? Journal de Gynecologie Obstetrique et Biologie de la Reproduction 19(6): 701-708
Giai, M.; Natoli, C.; Sismondi, P.; Biglia, N.; Lesti, G.; Mulieri, M.; Iacobelli, S. 1990: Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer Anticancer Research 10(1): 119-121
MJ Seibel; M Koeller; B van der Velden; I Diel 2002: Long-Term Variability of Bone Turnover Markers in Patients with Non-Metastatic Breast Cancer Clinical Laboratory 48(11-12): 579-582
Tanaka, R.; Fukushima, H.; Sato, K.; Matsuda, M.; Hanaoka, T.; Goya, T. 1999: Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(11): 1647-1650
Taguchi, T. 2018: Bone and calcium metabolism associated with malignancy. Clinical Characteristics and Treatment of Cancer Treatment Induced Bone Loss(CTIBL)in Breast Cancer Clinical Calcium 28(11): 1515-1517
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Murohashi, I.; Gomi, H.; Nakano, T.; Morita, S.; Arai, T.; Jinnai, I.; Nara, N.; Bessho, M.; Hirashima, K. 1986: Relationship of bone marrow dose to eosinophilia following radiotherapy: a study of patients with breast, lung, cervical, and ovarian cancer Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(7): 1368-1376
MJ Seibel; M Koeller; B van der Velden; I Diel 2002: Markers of Bone Turnover Do Not Predict Bone Metastases in Breast Cancer Clinical Laboratory 48(11-12): 583-588
van der Pluijm, G.; Vloedgraven, H.J.; Ivanov, B.; Robey, F.A.; Grzesik, W.J.; Robey, P.G.; Papapoulos, S.E.; Lowik, C.W. 1996: Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone Cancer Research 56(8): 1948-1955